Cormorant Asset Management LP 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:00 pm Sale | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 0 0.000% | -1,650,000 (Position Closed) | Filing |
| 2023-02-14 3:03 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 1,650,000 6.300% | 450,000 (+37.50%) | Filing |
| 2022-09-02 4:10 pm Purchase | 2022-08-23 | 13G | Astria Therapeutics, Inc. ATXS | Cormorant Asset Management LP | 1,200,000 5.380% | 1,200,000 (New Position) | Filing |